| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae64c775f32c43199adbb4389c2c9b3 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-67 |
| filingDate |
2010-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eda6b7f4491272c7eb6bb609bee7af2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dcaf1ceb56c319eb774432188e2a637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_127731dc38071e659f7a93449d314691 |
| publicationDate |
2012-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2012131726-A |
| titleOfInvention |
Oral composition and arginine dipine activity inhibitor |
| abstract |
The present invention provides an oral composition and an algin dipine activity inhibitor that have enhanced algin dipine activity inhibitory activity derived from gabexate mesilate and exhibit high algin dipine activity inhibitory effect. An oral composition comprising (A) gabexate mesylate and (B) an ascorbyl phosphate ester salt. (A) Argindipine activity inhibitor comprising gabexate mesylate and (B) ascorbic acid phosphate ester salt. [Selection figure] None |
| priorityDate |
2010-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |